<DOC>
	<DOCNO>NCT01025830</DOCNO>
	<brief_summary>The null hypothesis difference relative rate extent absorption systemic circulation Triomune brand-name Stavudine/Lamivudine/Nevirapine HIV-infected Africans alternative hypothesis difference relative rate extent absorption systemic circulation Triomune brand-name Stavudine/Lamivudine/Nevirapine HIV-infected Africans . This non-inferiority study .</brief_summary>
	<brief_title>Triomune Bioequivalence With Innovators</brief_title>
	<detailed_description>Generic antiretroviral therapy mainstay HIV treatment resource-limited setting , yet little evidence confirm bioequivalence generic brand name formulation . We compare steady-state pharmacokinetics Lamivudine , Stavudine Nevirapine HIV-infected subject receive generic formulation ( Triomune速 ) correspond brand formulation ( Epivir速 , Zerit速 , Viramune速 ) . An open-label , randomize , crossover study carry 18 HIV-infected Ugandan subject stabilize Triomune-40 . Subjects receive Lamivudine ( 150 mg ) , Stavudine ( 40 mg ) , Nevirapine ( 200 mg ) either generic brand formulation twice day 30 day , switch formulation . At end treatment period , blood sample collect 12 h pharmacokinetic analysis . The main outcome measure mean AUC0-12h Cmax . Bioequivalence define geometric mean ratio generic brand-name within 90 % confidence interval 0.8-1.25 .</detailed_description>
	<mesh_term>Nevirapine</mesh_term>
	<mesh_term>Stavudine</mesh_term>
	<mesh_term>Lamivudine</mesh_term>
	<criteria>1 . HIVinfected men nonpregnant woman ; 2 . On Triomune least 4 week ; 3 . 18 year great ; 4 . Residing within 15km Kampala city center 1 . Unable sign understand inform consent 2 . Concurrent medication know interact component Triomune 3 . Patients active TB , malabsorption , nausea , emesis , abdominal discomfort , chronic diarrhoea , document active clinically relevant hepatitis ; 4 . Patients expected change drug regimen dosage study 5 . Those plan move Kampala next two month ; 6 . Hemoglobin &lt; 7.0 mmol/l ( men ) &lt; 6.5 mmol/l ( woman ) ; 7 . Alanine aminotransferase aspartate aminotransferase &gt; 5 time upper limit normal ; 8 . Serum creatinine &gt; 1.5 time upper limit normal</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2009</verification_date>
	<keyword>HIV ; Bioequivalence ; Triomune</keyword>
</DOC>